Form 1-SA Standard Dental Labs For: Jun 30
http://archive.fast-edgar.com/20260929/A322O22CZ22HH9ZZ2C2K2ZYZ2PQ98ZN2Z282
Filed on: September 29, 2026
Form 4 H World Group Ltd For: Sep 26 Filed by: Jin Hui
http://archive.fast-edgar.com/20260929/AOBZO22D8C226TZ2222Q2ZZZD7OCZ2Q2DL82
Filed on: September 29, 2026
Form 8-K Keros Therapeutics, Inc. For: Sep 29
0001664710FALSE00016647102026-09-292026-09-29UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2026 Keros Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware001-3926481-1173868(state or other jurisdictionof incorporation)(CommissionFile Number)(I.R.S.... (continue reading...)
Form 6-K SaverOne 2014 Ltd. For: Sep 29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of September 2026 (Report No. 2)
Commission file number: 001-41387
SaverOne 2014 Ltd.
(Translation of registrant’s name into English)
Em Hamoshavot Rd. 94
Petah Tikvah, Israel
(Address of principal executive offices)
Form 8-A12B DYNEX CAPITAL INC
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 DYNEX CAPITAL, INC. (Exact name of registrant as specified in its charter) Virginia52-1549373(State of incorporation or organization)(I.R.S. Employer Identification No.)140 Eastshore Drive, Suite 100Glen Allen, Virginia23059-5755(Address of principal executive... (continue reading...)
More SEC Filings
View Older Stories-
Form SC TO-T/A ACV Auctions Inc. Filed by: COPART INC
-
Form S-3ASR MERCANTILE BANK CORP
-
Form 6-K MINISO Group Holding For: Sep 29
-
Form D/A MCorp a Series of CGF202
-
Form 8-K Imunon, Inc. For: Sep 28
-
Form 8-K TOP Financial Group Ltd For: Sep 25
-
Form 8-K Bloomin' Brands, Inc. For: Sep 25
-
Form 8-K FIRST UNITED CORP/MD/ For: Sep 24
-
Form 8-K Allarity Therapeutics, For: Sep 28
-
Form 8-K SurgePays, Inc. For: Sep 28
-
Form RW Syra Health Corp
-
Form 6-K POWERBANK Corp For: Sep 29
-
Form 8-K ATOSSA THERAPEUTICS, For: Sep 29
-
Form 6-K RoyaLand Co Ltd. For: Sep 29
-
Form 8-K TransDigm Group INC For: Sep 28
-
Form N-23C-2 OFS Credit Company, Inc. For: Sep 29
-
Form 497J Tidal Trust I
-
Form D/A Sensori April 2026 a
-
Form D/A Dart Financial Corp
-
Form D/A Auvi Labs Heinz Ventures
-
Form 485BXT GraniteShares ETF Trust
-
Form 40-17F2 BNY MELLON HIGH YIELD Filed by: BNY MELLON HIGH YIELD STRATEGIES FUND
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds I
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds II, Inc.
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds III
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds IV, Inc.
-
Form NT 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
Form 8-K Unicycive Therapeutics, For: Sep 28
-
Form D/A Declan Odyssey X a Serie
-
Form 8-K SOUNDTHINKING, INC. For: Sep 28
-
Form 485BXT GraniteShares ETF Trust
-
Form 424B2 TORONTO DOMINION BANK
-
Form D/A PRIVATEAIINVESTMENTSVLLC
-
Form 485BXT GraniteShares ETF Trust
-
Form 6-K Charming Medical Ltd For: Sep 29
-
Form 6-K Metalpha Technology Hold For: Sep 29
-
Form 18-K/A ONTARIO PROVINCE OF For: Mar 31
-
Form 6-K Glass House Brands Inc. For: Sep 29
-
Form 6-K Almonty Industries Inc. For: Sep 29
-
Form D VIRELTO LTD.
-
Form 8-K Cartesian Therapeutics, For: Sep 29
-
Form 6-K Central North Airport For: Sep 29
-
Form 6-K One & one Green Technolo For: Jun 30
-
Form 20-F Gamehaus Holdings Inc. For: Jun 30
-
Form 6-K MIXED MARTIAL ARTS GROUP For: Sep 29
-
Form 6-K Optimi Health Corp. For: Sep 29
-
Form 4 Qfin Holdings, Inc. For: Sep 29 Filed by: Yan Andrew Y
-
Form 8-K Invivyd, Inc. For: Sep 29
-
Form FWP Immix Biopharma, Inc. Filed by: Immix Biopharma, Inc.
-
Form 424B5 Immix Biopharma, Inc.

